Haemoglobin degradation and haem polymerization as antimalarial drug targets

Journal of Pharmacy and Pharmacology

Volumn 49, Issue SUPPL. 2, 1997, Pages 43-48

  Ridley, Robert G ^a,b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HEME; HEMOGLOBIN; PROTEINASE; RO 41 3118; RO 47 053; RO 47 9396; RO 48 0346; UNCLASSIFIED DRUG;

ARTICLE; DEGRADATION; DRUG TARGETING; ENZYME INHIBITION; POLYMERIZATION; STUDY;

EID: 0030962602     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06159.x     Document Type: Article

References (48)

1. Ball, E. G., McKee, R. W., Anfinsen, C. B., Cruz, W. O., Geumen, Q. M. (1948) Studies on malarial parasites IX. Chemical and metabolic changes during growth and multiplication in vivo and in vitro. J. Biol. Chem. 175: 547-571
2. Bohle, S. D., Conklin, B. J., Cox, D., Madsen, S. K., Paulson, S., Stephens, P. W., Yee, G. T. (1994) Structural and spectroscopic studies of β-hematin (the heme coordination polymer in malaria pigment). In: Wisian-Nielsen, P., Allcock, H. R., Wynne, K. J. (eds) ACS Symposium Series No. 572, Inorganic and Organometallic Polymers II: Advanced Materials and Intermediates. American Chemical Society, Columbus, Ohio, pp 497-515
3. Chou, A. C., Cherli, R., Fitch, C. D. (1980) Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19: 1543-1549
4. Dame, J. B., Reddy, G. R., Yowell, C. A., Dunn, B. M., Kay, J., Berry, C. (1994) Sequence, expression and modelled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 64: 177-190
5. de Gamboa, N. D., Rosenthal, P. J. (1996) Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malarial parasites. Blood 87: 4448-4454
6. Divo, A. A., Geary, T. G., Davis, N. L., Jensen, J. B. (1985) Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J Protozool 32: 59-64
7. Dorn, A., Stoffel, R., Matile, H., Bubendorf, A., Ridley, R. G. (1995) Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein. Nature 374: 269-271
8. Egan, T. J., Ross, D. C., Adams, P. A. (1994) Quinoline anti-malarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). FEBS Lett. 352: 54-57
9. Fitch, C. D., Chevli, R., Banyal, H. S., Phillips, G., Pfaller, M. A., Krogstad, D. J. (1982) Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex. Antimicrob. Agents Chemother. 21: 819-822
10. Fitch, C. D., Chevli, R., Kanjananggulpan, P., Dutta, P., Chevli, K., Chou, A. C. (1983) Intracellular ferriprotoporphyrin IX is a lytic agent. Blood 62: 1165-1168
11. Francis, S. E., Gluzman, I. Y., Oksman, A., Knickerbocker, A., Mueller, R., Bryant, M. L., Sherman, D. R., Russell, D. G., Goldberg, D. E. (1994) Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J. 13: 306-317
12. Fusek, M., Vetvicka, V. (1995) Aspartic Proteinases: Physiology and Pathology. CRC Press Inc., Boca Raton, Florida
13. Gluzman, I. Y., Francis, S. E., Oksman, A., Smith, C. E., Duffin, K. L, Goldberg, D. E. (1994) Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93: 1602-1608
14. Goldberg, D. E., Slater, A. F. G., Cerami, A., Henderson, G. B. (1990) Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc. Natl Acad. Sci. USA 87: 2931-2935
15. Goldberg, D. E., Slater, A. F. G., Beavis, R., Chait, B., Cerami, A., Henderson, G. B. (1991) Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J. Exp. Med. 173: 961-969
16. Good, M. I, Shader, R. I. (1982) Lethality and behavioural side effects of chloroquine. J. Clin. Psychopharmacol. 2: 40-47
17. Groman, N. B. (1951) Dynamic aspects of the nitrogen metabolism of Plasmodium gallinaceum in vivo and in vitro. J. Infect. Dis. 88: 126-150
18. Haynes, R. K., Vonwiller, S. C. (1996) The behaviour of qinghaosu (artemisinin) in the presence of heme iron (II) and (III). Tetrahedron Lett. 37: 253-256
19. Hill, J., Tyas, L., Phylip, L. H., Kay, J., Dunn, B. M., Berry, C. (1994) High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum. FEBS Lett. 352: 155-158
20. Kelly, J. C., Wasserman, G. S., Bernard, W. D., Schulz, C., Knapp, J. F. (1990) Chloroquine poisoning in a child. Ann. Emerg. Med. 19: 47-50
21. Li, R., Kenyon, G. L., Cohen, F. E., Chen, X., Gong, B., Dominguez, J. N., Davidson, E., Kurzban, G., Miller, R. E., Nuzum, E. O. Rosenthal, P. J., McKerrow , J. H. (1995) In vitro antimalarial activity of chalcones and their derivatives. J Med Chem 38: 5031-5037
22. Luker, K. E., Francis, S. E., Gluzman, I. Y., Goldberg, D. E. (1996) Kinetic analysis of plasmepsins I and II, aspartic proteases of the Plasmodium falciparum digestive vacuole. Mol. Biochem. Parasitol. 79: 71-78
23. Meshnick, S. R., Taylor, T. E., Kamchonwongpaisan, S. (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60: 301-315
24. Moon, R. P., Tyas, L., Certa, U., Rupp, K., Bur, D., Jaquet, C., Matile, H., Loetscher, H., Grueninger-Leitch, F., Kay, J., Dunn, B. M., Berry, C., Ridley, R. G. (1997) Expression and characterisation of plasmepsin I from Plasmodium falciparum. Eur. J. Biochem. In Press
25. Olliaro, P. L., Goldberg, D. E. (1995) The plasmodium digestive vacuole: Metabolic headquarters and choice drug target. Parasitol. Today 11: 294-297
26. Posner, G. H. (1997) Antimalarial endoperoxides that are potent and easily synthesized. J. Pharm. Pharmacol. 49 (Suppl. 2): 55-57
27. Rangachari, K., Dluzewski, A. R., Wilson, R. J., Gratzer, W. B. (1987) Cytoplasmic factor required for entry of malaria parasites into RBCs. Blood 70: 77-82
28. Ridley, R. G. (1996) Haemozoin formation in malaria parasites: is there a haem polymerase? Trends Microbiol. 4: 253-254
29. Ridley, R. G., Hofheinz, W., Matile, H., Jaquet, C., Dorn, A., Masciadri, R., Jolidon, S., Richter, W. F., Guenzi, A., Girometta, M.-A., Urwyler, H., Huber, W., Thaithong, S., Peters, W. (1996) 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 40: 1846-1854
30. 2-bis(7-chloroquinolin-4-yl)cyclohexane-1,2-diamine. A comparison of two stereoisomers and a detailed evaluation of the (S,S)-enantiomer, Ro 47-7737. Antimicrob. Agents Chemother. In Press
31. Ring, C. S., Sun, E., McKerrow, J. H., Lee, G. K., Rosenthal, P.J., Kuntz, I. D., Cohen, F. E. (1993) Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc. Natl Acad. Sci. USA 90: 3583-3587
32. Rosenthal, P. J. (1996) Conservation of key amino acids among the cysteine proteinases of multiple malarial species. Mol. Biochem. Parasitol. 75: 255-260
33. Rosenthal, P. J., McKerrow, J. H., Aikawa, M., Nagasawa, H., Leech, J. H. (1988) A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Invest. 82: 1560-1566
34. Rosenthal, P. J., McKerrow, J. H., Rasnick, D., Leech, J. H. (1989) Inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. Mol. Biochem. Parasitol. 35: 177-184
35. Rosenthal, P. J., Wollish, W. S., Palmer, J. T., Rasnick, D. (1991) Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J. Clin. Invest. 88: 1467-1472
36. Rosenthal, P. J., Lee, G. K., Smith, R. E. (1993) Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J. Clin. Invest. 91: 1052-1056
37. Rosenthal, P. J., Olsen, J. E., Lee, G. K., Palmer, J. T., Klaus, J. L., Rasnick, D. (1996) Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob. Agents Chemother. 40: 1600-1603
38. Roth Jr., E. F., Brotman, D. S., Vanderberg, J. P., Schulman, S. (1986) Malarial pigment error in the estimation of hemoglobin content in Plasmodium falciparum in infected red cells: implications for metabolic and biochemical studies of the erythrocytic phases of malaria. Am. J. Trop. Med. Hyg. 35: 906-911
39. Salas, F., Fichmann, J., Lee, G. K., Scott, M. D., Rosenthal, P. J. (1995) Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect. Immun. 63: 2120-2125
40. Schacter, B. A. (1988) Heme catabolism by heme oxygenase: physiology, regulation and mechanism of action. Sem. Hematol. 25: 349-369
41. Silva, A. M., Lee, A. Y., Gulnik, S. V., Maier, P., Collins, J., Bhat, T. N., Collins, P. J., Cacheu, R. E., Luker, K., Gluzman, I. Y., Francis, S. E., Oksman, A., Goldberg, D. E., Erickson, J. W. (1996) Structure and inhibition of plasmepsin II, a haemoglobin-degrading enzyme from Plasmodium falciaprum. Proc. Natl Acad. Sci. USA 93: 10034-10039
42. Slater, A. F. G., Cerami, A. (1992) Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355: 167-169
43. Slater, A. F. G., Swiggard, W. J., Orton, B. R., Flitter, W. D., Goldberg, D. E., Cerami, A., Henderson, G. B. (1991) An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl Acad. Sci. USA 88: 325-329
44. Sullivan Jr., D. J., Gluzman, I. Y., Goldberg, D. E. (1996) Plasmodium hemozoin formation mediated by histidine-rich proteins. Science 271: 219-222
45. Vander Jagt, D. L., Hunsaker, L. A., Campos, N. M., Scaletti, J. V. (1992) Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum. Biochim. Biophys. Acta 1122: 256-264
46. Vennerstrom, J. L., Ellis, W. Y., Ager Jr., A. L., Andersen, S. L., Gerena, L., Milhous, W. K. (1992) Bisquinolines. 1. N,N-Bis(7-chloroquinolin-4yl)alkanediamines with potential against chloroquine-resistant malaria. J. Med. Chem. 35: 2129-2134
47. Ward, S. A., Bray, P. G., Mungthin, M., Hawley, S. R. (1995) Current views on the mechanisms of resistance to quinoline-containing drugs in Plasmodium falciparum. Ann. Trop. Med. Parasitol. 89: 121-124
48. Zarchin, S., Krugliak, M., Ginsburg, H. (1986) Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials. Biochem. Pharmacol. 35: 2435-2442